Independent Review of GHIF Suggests the Fund is Performing Against Original Impact Investment Objectives

Innovative financing model shows promise for supporting global health research and development in a sustainable manner

FRANKFURT – December 21, 2016 – In mid-2016, KfW Development Bank, an anchor investor in GHIF, commissioned an independent mid-term review of the fund’s performance against its original objectives of generating meaningful improvements in global public health through investments in new or improved technologies for neglected diseases and maternal and child health challenges.  KfW recently published a report summarizing GHIF’s strategy and mid-term performance, which is available here.